Champion Homes (SKY) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.93 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +24.69%. A quarter ago, it was expected that this manufactured and modular housing maker would post earnings of $0.88 per share when it actually produced earnings of $1.19, delivering a surprise of +35.23%.Over the l ...

Paylocity (PCTY) came out with quarterly earnings of $1.75 per share, beating the Zacks Consensus Estimate of $1.5 per share. This compares to earnings of $1.66 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +16.67%. A quarter ago, it was expected that this provider of cloud-based payroll and human-resources software services would post earnings of $1.38 per share when it actually produced earnings of $1.56, delivering a surp ...

Core Insights - GoodRx Holdings, Inc. reported quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share, representing an earnings surprise of -11.11% [1] - The company posted revenues of $196.03 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.34% [2] - GoodRx shares have declined approximately 28.8% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Earnings Performance - Over the last four quarters, GoodRx has not surpassed consensus EPS estimates, with the most recent earnings matching the previous year's figure of $0.08 per share [1][2] - The current consensus EPS estimate for the upcoming quarter is $0.10, with projected revenues of $196.93 million, and for the current fiscal year, the estimate is $0.38 on revenues of $796.43 million [7] Market Outlook - The sustainability of GoodRx's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The Zacks Rank for GoodRx is currently 3 (Hold), indicating that shares are expected to perform in line with the market in the near future [6] Industry Context - The Medical Services industry, to which GoodRx belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Another company in the same industry, DocGo Inc., is expected to report a quarterly loss of $0.09 per share, reflecting a significant year-over-year decline [9]

Core Insights - Agilon Health (AGL) reported a quarterly loss of $0.27 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.18, marking an earnings surprise of -50.00% [1] - The company generated revenues of $1.44 billion for the quarter ended September 2025, slightly surpassing the Zacks Consensus Estimate by 0.57%, but down from $1.45 billion a year ago [2] - Agilon shares have declined approximately 57.4% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Financial Performance - Over the last four quarters, Agilon has exceeded consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.19 on revenues of $1.47 billion, and for the current fiscal year, it is -$0.56 on revenues of $5.82 billion [7] Market Outlook - The company's Zacks Rank is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] - The Medical Services industry, to which Agilon belongs, is ranked in the bottom 43% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Core Viewpoint - Oportun Financial Corporation reported quarterly earnings of $0.39 per share, significantly exceeding the Zacks Consensus Estimate of $0.26 per share, and showing a substantial increase from $0.02 per share a year ago, indicating strong financial performance [1][2]. Financial Performance - The company achieved revenues of $238.7 million for the quarter ended September 2025, slightly missing the Zacks Consensus Estimate by 0.06%, and down from $250 million in the same quarter last year [2]. - Over the last four quarters, Oportun Financial has consistently surpassed consensus EPS estimates, achieving this four times [2]. Stock Performance - Oportun Financial shares have increased approximately 38.1% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3]. - The stock currently holds a Zacks Rank of 3 (Hold), indicating expected performance in line with the market in the near future [6]. Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.30, with projected revenues of $241.56 million, and for the current fiscal year, the estimate is $1.24 on revenues of $952.28 million [7]. - The trend of earnings estimate revisions is mixed, which could influence future stock performance [6]. Industry Context - Oportun Financial operates within the Financial - Miscellaneous Services industry, which is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable industry outlook [8].

Core Insights - Par Petroleum (PARR) reported quarterly earnings of $5.95 per share, significantly exceeding the Zacks Consensus Estimate of $1.98 per share, and compared to a loss of $0.1 per share a year ago, representing an earnings surprise of +200.51% [1] - The company posted revenues of $2.01 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 5.40%, although this is a decrease from year-ago revenues of $2.14 billion [2] - Par Petroleum shares have increased by approximately 151.4% since the beginning of the year, outperforming the S&P 500's gain of 16.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.43 on revenues of $1.81 billion, and for the current fiscal year, it is $3.89 on revenues of $7.36 billion [7] - The estimate revisions trend for Par Petroleum was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Oil and Gas - Refining and Marketing industry is currently ranked in the top 18% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8] - Another company in the same industry, Delek US Holdings (DK), is expected to report quarterly earnings of $0.14 per share, reflecting a year-over-year change of +109.7%, with a consensus EPS estimate revised 36.9% higher over the last 30 days [9]

Core Insights - Unifi reported a quarterly loss of $0.56 per share, which was better than the Zacks Consensus Estimate of a loss of $0.60, representing an earnings surprise of +6.67% [1] - The company generated revenues of $135.67 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 0.31%, but down from $147.37 million a year ago [2] - Unifi's stock has underperformed, losing about 30.7% since the beginning of the year compared to the S&P 500's gain of 16.5% [3] Financial Performance - Over the last four quarters, Unifi has surpassed consensus EPS estimates three times [2] - The current consensus EPS estimate for the upcoming quarter is -$0.22 on revenues of $147.32 million, and for the current fiscal year, it is -$0.45 on revenues of $606.28 million [7] Market Outlook - The estimate revisions trend for Unifi was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] - The Zacks Industry Rank for Textile - Products is currently in the bottom 4% of over 250 Zacks industries, suggesting a challenging environment for stocks in this sector [8]

Core Insights - OmniAb, Inc. reported a quarterly loss of $0.14 per share, which aligns with the Zacks Consensus Estimate, showing an improvement from a loss of $0.16 per share a year ago [1] - The company's revenues for the quarter ended September 2025 were $2.24 million, missing the Zacks Consensus Estimate by 62.97% and down from $4.17 million year-over-year [2] - OmniAb's shares have declined approximately 58.2% year-to-date, contrasting with the S&P 500's gain of 16.5% [3] Financial Performance - The company has surpassed consensus EPS estimates only once in the last four quarters [1] - The current consensus EPS estimate for the upcoming quarter is -$0.15 on revenues of $7.15 million, and for the current fiscal year, it is -$0.59 on revenues of $21.52 million [7] Market Outlook - The earnings outlook and management's commentary during the earnings call will be crucial for assessing the stock's immediate price movement [3][4] - The Zacks Rank for OmniAb is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Medical - Drugs industry, to which OmniAb belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable environment for stocks in this sector [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Upstart Holdings, Inc. reported quarterly earnings of $0.52 per share, exceeding the Zacks Consensus Estimate of $0.42 per share, and showing a significant improvement from a loss of $0.06 per share a year ago, resulting in an earnings surprise of +23.81% [1] - The company achieved revenues of $277.11 million for the quarter ended September 2025, which was slightly below the Zacks Consensus Estimate by 1.39%, but represented a year-over-year increase from $162.14 million [2] - Upstart has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] Earnings Outlook - The future performance of Upstart's stock will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.54, with expected revenues of $302.78 million, and for the current fiscal year, the consensus EPS estimate is $1.66 on revenues of $963.44 million [7] Industry Context - The Financial - Miscellaneous Services industry, to which Upstart belongs, is currently ranked in the top 32% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The performance of Upstart's stock may also be influenced by the overall industry outlook, as empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]

Group 1 - Asian AI-linked companies' shares declined, influenced by falling U.S. peers and investor concerns over high valuations in crowded trades [1] - SoftBank's shares dropped by 10%, while Advantest's shares fell over 8% [1] - Palantir's shares decreased by approximately 8% despite exceeding third-quarter expectations, reflecting negative sentiment towards high valuations in the AI sector [2]